Albert Seymour - Jan 9, 2023 Form 4/A - Amendment Insider Report for Homology Medicines, Inc. (FIXX)

Role
President and Chief Executive Officer, Director
Signature
/s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
Stock symbol
FIXX
Transactions as of
Jan 9, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/20/2023, 03:05 PM
Date Of Original Report
Jan 11, 2023
Previous filing
Jan 4, 2023
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FIXX Common Stock 148K Jan 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct the aggregate common stock holdings of the Reporting Person. The common stock holdings in column 5 of Table I have been increased by 4,536 shares acquired under the Issuer's Employee Stock Purchase Plan on dates ranging from February 28, 2019 to August 31, 2021, which were previously inadvertently omitted.

Remarks:

President and Chief Executive Officer